CellaVision AB (CLVSF)
14.00
0.00 (0.00%)
USD |
OTCM |
Oct 16, 16:00
CellaVision SG&A Expense (TTM) : 24.96M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 24.96M |
| March 31, 2026 | 23.39M |
| December 31, 2025 | 22.49M |
| September 30, 2025 | 22.00M |
| June 30, 2025 | 21.86M |
| March 31, 2025 | 21.15M |
| December 31, 2024 | 20.99M |
| September 30, 2024 | 20.74M |
| June 30, 2024 | 20.38M |
| March 31, 2024 | 20.12M |
| December 31, 2023 | 20.03M |
| September 30, 2023 | 18.99M |
| June 30, 2023 | 18.54M |
| March 31, 2023 | 18.87M |
| December 31, 2022 | 19.02M |
| September 30, 2022 | 20.19M |
| June 30, 2022 | 20.21M |
| March 31, 2022 | 19.69M |
| December 31, 2021 | 19.25M |
| September 30, 2021 | 18.79M |
| June 30, 2021 | 17.52M |
| March 31, 2021 | 16.58M |
| December 31, 2020 | 16.46M |
| September 30, 2020 | 17.16M |
| June 30, 2020 | 17.44M |
| Date | Value |
|---|---|
| March 31, 2020 | 17.39M |
| December 31, 2019 | 16.22M |
| September 30, 2019 | 14.54M |
| June 30, 2019 | 14.27M |
| March 31, 2019 | 13.83M |
| December 31, 2018 | 13.78M |
| September 30, 2018 | 13.34M |
| June 30, 2018 | 13.08M |
| March 31, 2018 | 12.71M |
| December 31, 2017 | 12.37M |
| September 30, 2017 | 11.64M |
| June 30, 2017 | 10.97M |
| March 31, 2017 | 10.56M |
| December 31, 2016 | 9.982M |
| September 30, 2016 | 10.04M |
| June 30, 2016 | 9.780M |
| March 31, 2016 | 9.698M |
| December 31, 2015 | 9.677M |
| September 30, 2015 | 10.32M |
| June 30, 2015 | 10.61M |
| March 31, 2015 | 11.38M |
| December 31, 2014 | 11.55M |
| September 30, 2014 | 11.04M |
| June 30, 2014 | 10.66M |
| March 31, 2014 | 10.22M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| ALR Technologies SG Ltd. | -- |
| Carasent AB | 4.543M |
| PHC Holdings Corp. | 931.36M |
| SyntheticMR AB | 0.00 |
| HealthStream, Inc. | 84.63M |